Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance

Endocrine-Related Cancer

Volumn 16, Issue 1, 2009, Pages 211-224

  Engelmann, D ^a   Koczan, D ^a   Ricken, P ^a   Rimpler, U ^a   Pahnke, J ^a   Li, Z ^a   Pützer, Brigitte M ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FRACTALKINE; PROTEIN RET; RET PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL STRAIN 3T3; CONTROLLED STUDY; DOWN REGULATION; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; INNATE IMMUNITY; MICROARRAY ANALYSIS; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NATURAL KILLER CELL; NEUROFIBROMATOSIS; NONHUMAN; SIPPLE SYNDROME; T LYMPHOCYTE; THYROID MEDULLARY CARCINOMA; UPREGULATION; ANIMAL; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MEDULLARY CARCINOMA; POINT MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID TUMOR;

ANIMALS; CARCINOMA, MEDULLARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; KILLER CELLS, NATURAL; MICE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; NIH 3T3 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POINT MUTATION; PROTO-ONCOGENE PROTEINS C-RET; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS;

EID: 65549083449     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0158     Document Type: Article

References (54)

1. Allavena P, Giardina G, Bianchi G & Mantovani A 1997 IL-15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium. Journal of Leukocyte Biology 61 729-735.
2. Bonni A, Brunet A, West AE, Datta SR, Takasu MA & Greenberg ME 1999 Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286 1358-1362.
3. van den Broek ME, Kagi D, Ossendorp F, Toes R, Vamvakas S, Lutz WK, Melief CJ, Zinkernagel RM & Hengartner H 1996 Decreased tumor surveillance in perforin-deficient mice. Journal of Experimental Medicine 184 1781-1790.
4. Chang L & Karin M 2001 Mammalian MAP kinase signalling cascades. Nature 410 37-40.
5. Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C, Martos JA & Moreno M 1997 The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 79 2320-2328.
6. Day TF, Guo X, Garrett-Beal L & Yang Y 2005 Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Developmental Cell 8 739-750.
7. Dimberg J, Dienus O, Lofgren S, Hugander A & Wagsater D 2007 Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients. International Journal of Colorectal Disease 22 1195-1200.
8. Drosten M & Pützer BM 2006 Mechanisms of disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy. Nature Clinical Practice. Oncology 3 564-574.
9. Eccles N, Ivan M & Wynford-Thomas D 1996 Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor. Molecular and Cellular Endocrinology 117 247-251.
10. Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G et al. 2001 Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. Journal of Clinical Investigation 107 1173-1181.
11. Fujita K & Janz S 2007 Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Molecular Cancer 6 71.
12. de Groot JW, Links TP, Plukker JT, Lips CJ & Hofstra RM 2006 RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocrine Reviews 27 535-560.
13. Grossman WJ, Revell PA, Lu ZH, Johnson H, Bredemeyer AJ & Ley TJ 2003 The orphan granzymes of humans and mice. Current Opinion in Immunology 15 544-552.
14. Guo J, Zhang M, Wang B, Yuan Z, Guo Z, Chen T, Yu Y, Qin Z & Cao X 2003 Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells. International Journal of Cancer 103 212-220.
15. Henkart PA 1994 Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1 343-346.
16. Hsia JY, Chen JT, Chen CY, Hsu CP, Miaw J, Huang YS & Yang CY 2005 Prognostic significance of intratumoral natural killer cells in primary resected esophageal squamous cell carcinoma. Chang Gung Medical Journal 28 335-340.
17. Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM & Long F 2005 Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132 49-60.
18. Hyakudomi M, Matsubara T, Hyakudomi R, Yamamoto T, Kinugasa S, Yamanoi A, Maruyama R & Tanaka T 2008 Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma. Annals of Surgical Oncology 15 1775-1782.
19. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Che X, Iwashige H, Aridome K, Hokita S & Aikou T 2000 Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 88 577-583.
20. Ivan M, Bond JA, Prat M, Comoglio PM & Wynford-Thomas D 1997 Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells. Oncogene 14 2417-2423.
21. Jain S, Watson MA, DeBenedetti MK, Hiraki Y, Moley JF & Milbrandt J 2004 Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors. Cancer Research 64 3907-3913.
22. Jeffers M, Rong S & Woude GF 1996 Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. Journal of Molecular Medicine 74 505-513.
23. Kawasaki A, Shinkai Y, Yagita H & Okumura K 1992 Expression of perforin in murine natural killer cells and cytotoxic T lymphocytes in vivo. European Journal of Immunology 22 1215-1219.
24. Kebache S, Ash J, Annis MG, Hagan J, Huber M, Hassard J, Stewart CL, Whiteway M & Nantel A 2007 Grb10 and active Raf-1 kinase promote Bad-dependent cell survival. Journal of Biological Chemistry 282 21873-21883.
25. Keefe D, Shi L, Feske S, Massol R, Navarro F, Kirchhausen T & Lieberman J 2005 Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis. Immunity 23 249-262.
26. Kobayashi M, Taniura H & Yoshikawa K 2002 Ectopic expression of necdin induces differentiation of mouse neuroblastoma cells. Journal of Biological Chemistry 277 42128-42135.
27. Kojima H, Shinohara N, Hanaoka S, Someya-Shirota Y, Takagaki Y, Ohno H, Saito T, Katayama T, Yagita H, Okumura K et al. 1994 Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1 357-364.
28. Kuniyasu H, Oue N, Nakae D, Tsutsumi M, Denda A, Tsujiuchi T, Yokozaki H & Yasui W 2001 Interleukin-15 expression is associated with malignant potential in colon cancer cells. Pathobiology 69 86-95.
29. Lakhani VT, You YN & Wells SA 2007 The multiple endocrine neoplasia syndromes. Annual Review of Medicine 58 253-265.
30. Lavergne E, Combadiere B, Bonduelle O, Iga M, Gao JL, Maho M, Boissonnas A, Murphy PM, Debre P & Combadiere C 2003 Fractalkine mediates natural killer-dependent antitumor responses in vivo. Cancer Research 63 7468-7474.
31. Lieberman J 2003 The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nature Reviews. Immunology 3 361-370.
32. Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH & Hannon GJ 1999 Twist is a potential oncogene that inhibits apoptosis. Genes and Development 13 2207-2217.
33. Miše N, Drosten M, Racek T, Tannapfel A & Putzer BM 2006 Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2. Oncogene 25 6637-6647.
34. Mlodzik M 2002 Planar cell polarization: do the same mechanisms regulate Drosophila tissue polarity and vertebrate gastrulation? Trends in Genetics 18 564-571.
35. Ohta M, Tanaka F, Yamaguchi H, Sadanaga N, Inoue H & Mori M 2005 The high expression of Fractalkine results in a better prognosis for colorectal cancer patients. International Journal of Oncology 26 41-47.
36. Plaza-Menacho I, Burzynski GM, de Groot JW, Eggen BJL & Hofstra RMW 2006 Current concepts in RET-related genetics, signaling and therapeutics. Trends in Genetics 22 627-636.
37. Ruco LP, Stoppacciaro A, Ballarini F, Prat M & Scarpino S 2001 Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis. Journal of Pathology 194 4-8.
38. Russell JH & Ley TJ 2002 Lymphocyte-mediated cytotoxicity. Annual Review of Immunology 20 323-370.
39. Salvatore D, Melillo RM, Monaco C, Visconti R, Fenzi G, Vecchio G, Fusco A & Santoro M 2001 Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B. Cancer Research 61 1426-1431.
40. Sekiya T, Adachi S, Kohu K, Yamada T, Higuchi O, Furukawa Y, Nakamura Y, Nakamura T, Tashiro K, Kuhara S et al. 2004 Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. Journal of Biological Chemistry 279 6840-6846.
41. Shi L, Mai S, Israels S, Browne K, Trapani JA & Greenberg AH 1997 Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization. Journal of Experimental Medicine 185 855-866.
42. Smyth MJ, Kershaw MH, Darcy PK & Trapani JA 1998 Adoptive transfer: the role of perforin in mouse cytotoxic T lymphocyte rejection of human tumor xenografts in vivo. Xenotransplantation 5 146-153.
43. Smyth MJ, Thia KY, Cretney E, Kelly JM, Snook MB, Forbes CA & Scalzo AA 1999 Perforin is a major contributor to NK cell control of tumor metastasis. Journal of Immunology 162 6658-6662.
44. Takahashi M, Ritz J & Cooper GM 1985 Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42 581-588.
45. Takanami I, Takeuchi K & Giga M 2001 The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery 121 1058-1063.
46. Taniura H, Matsumoto K & Yoshikawa K 1999 Physical and functional interactions of neuronal growth suppressor necdin with p53. Journal of Biological Chemistry 274 16242-16248.
47. Thomas JT, Lin K, Nandedkar M, Camargo M, Cervenka J & Luyten FP 1996 A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nature Genetics 12 315-317.
48. Trovato M, Villari D, Bartolone L, Spinella S, Simone A, Violi MA, Trimarchi F, Batolo D & Benvenga S 1998 Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules. Thyroid 8 125-131.
49. Vitale S, Cambien B, Karimdjee BF, Barthel R, Staccini P, Luci C, Breittmayer V, Anjuere F, Schmid-Alliana A & Schmid-Antomarchi H 2007 Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer. Gut 56 365-372.
50. Watanabe T, Ichihara M, Hashimoto M, Shimono K, Shimoyama Y, Nagasaka T, Murakumo Y, Murakami H, Sugiura H, Iwata H et al. 2002 Characterization of gene expression induced by RET with MEN2A or MEN2B mutation. American Journal of Pathology 161 249-256.
51. Xin H, Kikuchi T, Andarini S, Ohkouchi S, Suzuki T, Nukiwa T, Huqun, Hagiwara K, Honjo T & Saijo Y 2005 Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells. European Journal of Immunology 35 1371-1380.
52. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A & Weinberg RA 2004 Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117 927-939.
53. Zeng Q, Chen S, You Z, Yang F, Carey TE, Saims D & Wang CY 2002 Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B. Journal of Biological Chemistry 277 25203-25208.
54. Zeng Y, Huebener N, Fest S, Weixler S, Schroeder U, Gaedicke G, Xiang R, Schramm A, Eggert A, Reisfeld RA et al. 2007 Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells. Cancer Research 67 2331-2338.